Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing Albert Bourla talks about his employees' effort to develop a COVID-19 vaccine in record ...
Despite these challenges, Pfizer maintains a strong cash position of $7.1 billion and offers an attractive forward dividend ...
Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to ...
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback